Jumping the gun on hydroxychloroquine
Hydroxychloroquine is in high demand because of its yet-unproven potential to fight COVID-19. But that means the people who really need it are having trouble getting it.
Listen 15:48
A bottle of hydroxychloroquine.(Courtesy of Susan Hauk)
Listen to The Why wherever you get your podcasts:
Apple Podcasts | Google Podcasts | Stitcher | RadioPublic | TuneIn
President Donald Trump has been pushing a drug called hydroxychloroquine as a game-changer in the fight against COVID-19 — but its effectiveness against the coronavirus has not been proven. As clinical trials get underway, including one in Philly, a look at why people are scrambling to get their hands on this drug, including those who need it for other serious health problems.
Guests: WHYY Morning Edition host Jennifer Lynn and health reporter Alan Yu
WHYY is your source for fact-based, in-depth journalism and information. As a nonprofit organization, we rely on financial support from readers like you. Please give today.
Brought to you by The Why
The Why
There’s more to every story if you take the time to tell it.
Syphilis cases are rising sharply in Pa., N.J. and Del., new federal data shows
Public health experts say targeted investments in sexual health education, testing and treatment are needed to bring down syphilis infections.
10 months ago
Listen 1:15
Pennsylvania’s health system is among the nation’s best, according to latest scorecard ranking
The Commonwealth Fund’s 2023 state scorecard also graded New Jersey and Delaware as having a “better-than-average” health system performance.
1 year ago
Tobacco control in the Delaware Valley improves slightly, but funding falls short
The American Lung Association's annual State of Tobacco Control report shows some progress in reducing smoking-related illnesses, but gaps remain.
2 years ago
Listen 1:17